Corbus Pharmaceuticals Holdings (CRBP) Earnings Date & Reports

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CRBP is expected to report earnings to rise 2.44% to -125 cents per share on August 11

Corbus Pharmaceuticals Holdings CRBP Stock Earnings Reports

Q2'26

Est.

$-1.26

Q1'26

Beat

by $0.15

Q4'25

Beat

by $0.14

Q3'25

Missed

by $0.62

Q2'25

Missed

by $0.21

The last earnings report on May 12 showed earnings per share of -123 cents, beating the estimate of -137 cents. With 120.86K shares outstanding, the current market capitalization sits at 154.52M.

View a ticker or compare two or three

Compare

CRBP

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CRBP